Literature DB >> 978397

Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.

V F Smolen.   

Abstract

Mesh：

Year:  1976        PMID： 978397     DOI： 10.1007/BF01063124

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  15 in total

1.  Optimally predictive in vitro drug dissolution testing for in vivo bioavailability.

Authors:  V F Smolen; W A Weigand
Journal:  J Pharm Sci       Date:  1976-12       Impact factor: 3.534

2.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

3.  Application of analogue computer to measurement of intestinal absorption rates with tracers.

Authors:  M SILVERMAN; A S BURGEN
Journal:  J Appl Physiol       Date:  1961-09       Impact factor: 3.531

4.  The precursor-product relationship.

Authors:  A RESCIGNO; G SEGRE
Journal:  J Theor Biol       Date:  1961-10       Impact factor: 2.691

5.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

6.  Drug input optimization: bioavailability-effected time-optimal control of multiple, simultaneous, pharmacological effects and their interrelationships.

Authors:  V F Smolen; B D Turrie; W A Weigand
Journal:  J Pharm Sci       Date:  1972-12       Impact factor: 3.534

7.  Determination of time course of in vivo pharmacological effects from in vitro drug-release testing.

Authors:  V F Smolen
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

8.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

9.  Studies on absorption and excretion of drug. VII. A new estimation method for the release of drugs from dosage forms and the availability in vivo.

Authors:  M Hanano
Journal:  Chem Pharm Bull (Tokyo)       Date:  1967-07       Impact factor: 1.645

10.  Release of a drug from a dosage form.

Authors:  H Stelmach; J R Robinson; S P Eriksen
Journal:  J Pharm Sci       Date:  1965-10       Impact factor: 3.534
View more
  8 in total

1.  Volterra series in pharmacokinetics and pharmacodynamics.

Authors:  Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-10       Impact factor: 2.745

Review 2.  Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

Authors:  W R Gillespie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

3.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

4.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

5.  Linear systems analysis in pharmacokinetics.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

6.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

7.  Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN spray.

Authors:  C de Mey; K Erb; T Zimmermann; H Mutschler; H Blume; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Semiparametric analysis of non-steady-state pharmacodynamic data.

Authors:  D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1991-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.